Stephen Hoge insider trades

Open-market stock purchases and sales by Stephen Hoge, President at Moderna, Inc, from SEC Form 4 filings since Dec 11, 2018.

Recent trades

DateStockTradeValue
Oct 15, 2026MRNA Moderna, IncSold$8.6M
Oct 15, 2026MRNA Moderna, IncBought (not open market)$933K
Oct 15, 2026MRNA Moderna, IncBought (not open market)—
Oct 14, 2026MRNA Moderna, IncSold$8.3M
Oct 14, 2026MRNA Moderna, IncSold$96.4K
Oct 14, 2026MRNA Moderna, IncBought (not open market)$933K
Oct 14, 2026MRNA Moderna, IncBought (not open market)—
Sep 15, 2026MRNA Moderna, IncSold$5.9M
Sep 15, 2026MRNA Moderna, IncBought (not open market)—
Sep 14, 2026MRNA Moderna, IncSold$5.8M
Sep 14, 2026MRNA Moderna, IncBought (not open market)—
Sep 1, 2026MRNA Moderna, IncSold (not open market)$630K
Sep 1, 2026MRNA Moderna, IncBought (not open market)—
Aug 28, 2026MRNA Moderna, IncSold (not open market)$42.3K
Aug 28, 2026MRNA Moderna, IncBought (not open market)—
Aug 27, 2026MRNA Moderna, IncSold (not open market)$104K
Aug 27, 2026MRNA Moderna, IncBought (not open market)—
Jul 15, 2026MRNA Moderna, IncSold$3.6M
Jul 15, 2026MRNA Moderna, IncBought (not open market)—
Jul 15, 2026MRNA Moderna, IncBought (not open market)—
Jun 15, 2026MRNA Moderna, IncSold$2.7M
Jun 15, 2026MRNA Moderna, IncBought (not open market)—
Jun 15, 2026MRNA Moderna, IncBought (not open market)—
Jun 1, 2026MRNA Moderna, IncBought (not open market)—
Jun 1, 2026MRNA Moderna, IncSold (not open market)$212K

Companies traded

  • MRNA Moderna, Inc: 472 sales, last Oct 15, 2026
  • AXLA Axcella Health Inc: other filings, last May 20, 2021

Get free alerts when Stephen Hoge files a new trade →